VEA
SYRS

Virtus ETF Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Virtus ETF Advisers’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
2021
Q3 		$161K Sell
2021
Q2 		$207K Buy
2021
Q1 		$193K Buy
2020
Q4 		$275K Sell
2020
Q3 		$308K Sell
2020
Q2 		$422K Buy
2018
Q4 		– Sell
2018
Q3 		$424K Sell
2018
Q2 		$630K Buy